Combined immunosuppressive and surgical therapy of necrotic keratitis in rheumatoid arthritis;Nekrotisierende keratitiden bei chronischer polyarthritis kombinierte immunsuppressive und chirurgische therapie

Ophthalmologe

Volumn 95, Issue 9, 1998, Pages 619-624

  Wiezorrek, Ralph ^a   Bialasiewicz, Alexander Arthur ^a   Engelmann, Katrin ^a   Grasedyck, Knut ^a   Richard, Gisbert ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Corneal ulcus; Immunosuppression; Rheumatoid arthritis

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ADULT; AGED; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATITIS; MALE; PENETRATING KERATOPLASTY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0031713709     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003470050324     Document Type: Article

References (15)

1. Bialasiewicz AA, Naumann GOH (1988) Tektonische Keratoplastik bei perforiertem Hornhautulcus bei Sjögren-Syndrom. Klin Mbl Augenheilkd 193: 554-564
2. Bialasiewicz AA, Fuisting B, Grasedyck K, Richard G (1995) Ophthalmochirurgische Aspekte bei chronischer Polyarthritis. Akt Augenheilkd 20: 254-262
3. Cibere J, Sibley J, Haga M (1997) Rheumatoid arthritis and the risk of malignancy. Arthr Rheumatism 40: 1580-1586
4. Edwards KK, Lindsley HB, Lai CW, Van Veldhuizen PJ (1989) Takayasu arteritis presenting as retinal and vertebrobasilar ischemia. J Rheumathol 16: 1000-1002
5. Foster CS (1980) Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology 87: 140-149
6. Foster CS, Forstot SL, Wilson LA (1984) Mortality Rate in rheumatoid arthritis patients developing necrotising scleritis or peripheral ulcerative keratitis: effects of systemic immunosuppression. Ophthalmology 91: 1253-1263
7. Hamza M, Meddeb S, Mili I, Quertani A (1992) Bolus of cyclophosphamide or methyl-prednisolone in uveitis in Behçet's disease. Preliminary results with the use of new criteria of evaluation. Ann Med Interne (Paris) 143: 438-441
8. Jabs DA (1993) Ocular manifestations of the rheumatic diseases. In: Tasman W, Jaeger E (eds) Duane's clinical ophthalmology, vol 5, 26. Lippincott, Philadelphia pp 1-39
9. Jayson MIV, Jones DEP (1971) Scleritis and rheumatoid arthritis. Ann Rheum Dis 30: 343-352
10. McGavin DDM, Wiiliamson J, Forester JV (1976) Episcleritis and scleritis: a study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol 60: 192-197
11. Radis CD, Kahl LE, Baker GL, Wasko MCM, Cash JM, Gallatin A, Stolzer BL, Agarwal AK, Medsger TA, Kwoh CK (1995) Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. Arthr Rheum 38: 1120-1127
12. Reinhold-Keller, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL (1994) Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with wegener's granulomatosis. Arthr Rheum 37: 919-924
13. Thompson MS, Eadie S (1956) Keratokonjunctivitis sicca and rheumatoid arthritis. Ann Rheum Dis 5: 21-23
14. Tishler M, Caspi D, Yaron M (1993) Long-term experience with low dose methotrexate in rheumathoid arthritis. Rheumatol Intern 13: 103-106
15. Watson PG, Hayreh SS (1976) Scleritis and episcleritis. Br J Ophthalmol 60: 163-191